1,25(OH)2D3-enhanced hypercalciuria in genetic hypercalciuric stone-forming rats fed a low-calcium diet

American Journal of Physiology - Renal Physiology

Volumn 305, Issue 8, 2013, Pages

  Frick, Kevin K ^a   Asplin, John R ^b   Krieger, Nancy S ^a   Culbertson, Christopher D ^a   Asplin, Daniel M ^b   Bushinsky, David A ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b LithoLink Corporation   (United States)

Author keywords

Calcium; Intestinal absorption; Kidney stones; Vitamin D

Indexed keywords

1,25 HYDROXYVITAMIN D3; CALCIUM; KLOTHO PROTEIN; RNA; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D RECEPTOR; CALCITRIOL; CALCITRIOL RECEPTOR; CALCIUM INTAKE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE CELL; BONE MINERAL; CALCIUM ABSORPTION; CALCIUM TRANSPORT; CALCIUM URINE LEVEL; CONTROLLED STUDY; DIET; GENE EXPRESSION; IDIOPATHIC HYPERCALCIURIA; INTESTINE ABSORPTION; KIDNEY TUBULE ABSORPTION; LOW CALCIUM DIET; MALE; NONHUMAN; OSTEOLYSIS; PRIORITY JOURNAL; RAT; ADMINISTRATION AND DOSAGE; ANIMAL; CALCIUM INTAKE; CHEMICALLY INDUCED; DISEASE MODEL; GENETICS; HYPERCALCEMIA; HYPERCALCIURIA; METABOLISM; NEPHROLITHIASIS; PHYSIOLOGY; SPRAGUE DAWLEY RAT; URINE;

ANIMALS; CALCITRIOL; CALCIUM; CALCIUM, DIETARY; DISEASE MODELS, ANIMAL; HYPERCALCEMIA; HYPERCALCIURIA; INTESTINAL ABSORPTION; KIDNEY CALCULI; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CALCITRIOL;

EID: 84885591283     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00296.2013     Document Type: Article

References (63)

1. Adams ND, Gray RW, Lemann JJ. Effects of calcitriol administration on calcium metabolism in healthy men. Kidney Int 21: 90-97, 1982.
2. Alexander RT, Woudenberg-Vrenken TE, Buurman J, Dijkman H, van der Eerden BCJ, van Leeuwen JPTM, Bindels RJ, Hoenderop JG. Klotho prevents renal calcium loss. J Am Soc Nephrol 20: 2371-2379, 2009.
3. Asplin JR, Bushinsky DA, Singharetnam W, Riordon D, Parks JH, Coe FL. Relationship between supersaturation and crystal inhibition in hypercalciuric rats. Kidney Int 51: 640-645, 1997.
4. Asplin JR, Donahue SE, Lindeman C, Michalenka A, Strutz KL, Bushinsky DA. Thiosulfate reduces calcium phosphate nephrolithiasis. J Am Soc Nephrol 20: 1246-1253, 2009.
5. Bai S, Wang H, Shen J, Zhou R, Bushinsky DA, Favus MJ. Elevated vitamin D receptor levels in genetic hypercalciuric stone-forming rats are associated with downregulation of Snail. J Bone Miner Res 25: 830-840, 2010.
6. Bataille P, Bouillion R, Fournier A, Renaud H, Gueris J, Idrissi A. Increased plasma concentrations of total and free 1,25(OH)2D3 in calcium stone formers with idiopathic hypercalciuria. Contr Nephrol 58: 137-142, 1987.
7. Bergsland KJ, Zisman AL, Asplin JR, Worcester EM, Coe FL. Evidence for net renal tubule oxalate secretion in patients with calcium kidney stones. Am J Physiol Renal Physiol 300: F311-F318, 2011.
8. 2+ transport in primary cultures of rabbit kidney CCD: stimulation by 1,25-dihydroxyvitamin D3 and PTH. Am J Physiol Renal Fluid Electrolyte Physiol 261: F799-F807, 1991.
9. Blanchard A, Jeunemaitre X, Coudol P, Dechaux M, Froissart M, May A, Demontis R, Fournier A, Paillard M, Houillier P. Paracellin-1 is critical for magnesium and calcium reabsorption in the human thick ascending limb of Henle. Kidney Int 59: 2206-2215, 2001.
10. Broadus AE, Horst RL, Lang R, Littledike ET, Rasmussen H. The importance of circulating 1,25(OH)2D in the pathogenesis of hypercalciuria and renal stone formation in primary hyperparathyroidism. N Engl J Med 302: 421-426, 1980.
11. Bushinsky DA, Asplin JR. Thiazides reduce brushite, but not calcium oxalate, supersaturation and stone formation in genetic hypercalciuric stone-forming rats. J Am Soc Nephrol 16: 417-424, 2005.
12. Bushinsky DA, Asplin JR, Grynpas MD, Evan AP, Parker WR, Alexander KM, Coe FL. Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats. Kidney Int 61: 975-987, 2002.
13. Bushinsky DA, Bashir MA, Riordon DR, Nakagawa Y, Coe FL, Grynpas MD. Increased dietary oxalate does not increase urinary calcium oxalate saturation in hypercalciuric rats. Kidney Int 55: 602-612, 1999.
14. Bushinsky DA, Coe FL, Moe OW. Nephrolithiasis. In: The Kidney, edited by Brenner BM. Philadelphia: W. B. Saunders, 2012, p. 1455-1507.
15. Bushinsky DA, Favus MJ. Mechanism of hypercalciuria in genetic hypercalciuric rats: inherited defect in intestinal calcium transport. J Clin Invest 82: 1585-1591, 1988.
16. Bushinsky DA, Grynpas MD, Asplin JR. Effect of acidosis on urine supersaturation and stone formation in genetic hypercalciuric stone forming rats. Kidney Int 59: 1415-1423, 2001.
17. Bushinsky DA, Grynpas MD, Nilsson EL, Nakagawa Y, Coe FL. Stone formation in genetic hypercalciuric rats. Kidney Int 48: 1705-1713, 1995.
18. Bushinsky DA, Kim M, Sessler NE, Nakagawa Y, Coe FL. Increased urinary saturation and kidney calcium content in genetic hypercalciuric rats. Kidney Int 45: 58-65, 1994.
19. Bushinsky DA, LaPlante K, Asplin JR. Effect of cinacalcet on urine calcium excretion and supersaturation in genetic hypercalciuric stoneforming rats. Kidney Int 69: 1586-1592, 2006.
20. Bushinsky DA, Lechleider RJ. Mechanism of proton-induced bone calcium release: calcium carbonate-dissolution. Am J Physiol Renal Fluid Electrolyte Physiol 253: F998-F1005, 1987.
21. Bushinsky DA, Michalenka AC, Strutz KL, Donahue S, Asplin JR. Effect of bolus and divided feeding on urine ions and supersaturation in genetic hypercalciuric stone-forming rats. Kidney Int 73: 423-429, 2007.
22. Bushinsky DA, Neumann KJ, Asplin J, Krieger NS. Alendronate decreases urine calcium and supersaturation in genetic hypercalciuric rats. Kidney Int 55: 234-243, 1999.
23. Bushinsky DA, Parker WR, Asplin JR. Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats. Kidney Int 57: 550-560, 2000.
24. Bushinsky DA, Willett T, Asplin JR, Culbertson C, Che SPY, Grynpas M. Chlorthalidone improves vertebral bone quality in genetic hypercalciuric stone-forming rats. J Bone Miner Res 26: 1904-1912, 2011.
25. Cha SK, Ortega B, Kurosu H, Rosenblatt KP, Kuro-o M, Huang CL. Removal of sialic acid involving Klotho causes cell-surface retention of TRPV5 channel via binding to galectin-1. Proc Natl Acad Sci USA 105: 9805-9810, 2008.
26. Cornet A, Baudet C, Neveu I, Baron-Van Evercooren A, Brachet P, Naveilhan P. 1,25-Dihydroxyvitamin D3 regulates the expression of VDR and NGF gene in Schwann cells in vitro. J Neurosci Res 53: 742-746, 1998.
27. Evan AP, Bledsoe SB, Smith SB, Bushinsky DA. Calcium oxalate crystal localization and osteopontin immunostaining in genetic hypercalciuric stone-forming rats. Kidney Int 65: 154-161, 2004.
28. Favus MJ, Karnauskas AJ, Parks JH, Coe FL. Peripheral blood monocyte vitamin D receptor levels are elevated in patients with idiopathic hypercalciuria. J Clin Endocrinol Metab 89: 4937-4943, 2004.
29. Frick K, Asplin J, Favus M, Culbertson C, Krieger N, Bushinsky D. Increased biological response to 1,25(OH)2D3 in genetic hypercalciuric stone-forming rats. Am J Physiol Renal Physiol 304: F718-F726, 2013.
30. Frick KK, Bushinsky DA. Molecular mechanisms of primary hypercalciuria. J Am Soc Nephrol 14: 1082-1095, 2003.
31. 2+ transport in response to CaSR signalling via a novel microRNA pathway. EMBO J 31: 1999-2012, 2012.
32. Grynpas M, Waldman S, Holmyard D, Bushinsky DA. Genetic hypercalciuric stone-forming rats have a primary decrease in bone mineral density and strength. J Bone Miner Res 24: 1420-1426, 2009.
33. Healy KD, Zella JB, Prahl JM, DeLuca HF. Regulation of the murine renal vitamin D receptor by 1,25-dihydroxyvitamin D3 and calcium. Proc Natl Acad Sci USA 100: 9733-9737, 2003.
34. Hoenderop JGJ, Nilius B, Bindels RJM. Calcium absorption across epithelia. Physiol Rev 85: 373-422, 2005.
35. Hoopes RR Jr, Middleton FA, Sen S, Hueber PA, Reid R, Bushinsky DA, Scheinman SJ. Isolation and confirmation of a calcium excretion quantitative trait locus on chromosome 1 in genetic hypercalciuric stone-forming congenic rats. J Am Soc Nephrol 17: 1292-1304, 2006.
36. Hoopes RR, Reid R, Sen S, Szpirer C, Dixon P, Pannet A, Thakker RV, Bushinsky DA, Scheinman SJ. Quantitative trait loci for hypercalciuria in a rat model of kidney stone disease. J Am Soc Nephrol 14: 1844-1850, 2003.
37. Hou J, Renigunta A, Gomes AS, Hou M, Paul DL, Waldegger S, Goodenough DA. Claudin-16 and claudin-19 interaction is required for their assembly into tight junctions and for renal reabsorption of magnesium. Proc Natl Acad Sci USA 106: 15350-15355, 2009.
38. Insogna KL, Broadus AE, Dryer BE, Ellison AF, Gertner JM. Elevated production rate of 1,25-dihydroxyvitamin D in patients with absorptive hypercalciuria. J Clin Endocrinol Metab 61: 490-495, 1985.
39. Joshi R. Hypercalcemia due to hypervitaminosis D: report of seven patients. J Trop Pediatr 55: 396-398, 2009.
40. Karnauskas AJ, van Leeuwen JP, van den Bemd GJ, Kathpalia PP, DeLuca HF, Bushinsky DA, Favus MJ. Mechanism and function of high vitamin D receptor levels in genetic hypercalciuric stone-forming rats. J Bone Miner Res 20: 447-454, 2005.
41. Kim M, Sessler NE, Tembe V, Favus MJ, Bushinsky DA. Response of genetic hypercalciuric rats to a low calcium diet. Kidney Int 43: 189-196, 1993.
42. Koul PA, Ahmad SH, Ahmad F, Jan RA, Shah SU, Khan UH. Vitamin d toxicity in adults: a case series from an area with endemic hypovitaminosis d. Omam Med J 26: 201-204, 2011.
43. Krieger NS, Stathopoulos VM, Bushinsky DA. Increased sensitivity to 1,25(OH)2D3 in bone from genetic hypercalciuric rats. Am J Physiol Cell Physiol 271: C130-C135, 1996.
44. Lemann J Jr, Pleuss JA, Worcester EA, Hornick L, Schrab D, Hoffman RG. Urinary oxalate excretion increases with body size and decreases with increasing dietary calcium intake among healthy adults. Kidney Int 49: 200-208, 1996.
45. Li XQ, Tembe V, Horwitz GM, Bushinsky DA, Favus MJ. Increased intestinal vitamin D receptor in genetic hypercalciuric rats: a cause of intestinal calcium hyperabsorption. J Clin Invest 91: 661-667, 1993.
46. 2+ channels TRPV5 and TRPV6. Nephrol Dial Transplant 23: 3397-3402, 2008.
47. Maierhofer WJ, Gray RW, Cheung HS, Lemann J Jr. Bone resorption stimulated by elevated serum 1,25-(OH)2-vitamin D3 concentrations in healthy men. Kidney Int 24: 555-560, 1983.
48. Moe OW, Bonny O. Genetic hypercalciuria. J Am Soc Nephrol 16: 729-745, 2005.
49. Monico CG, Milliner DS. Genetic determinants of urolithiasis. Nat Rev Nephrol 8: 151-162, 2012.
50. Monk RD, Bushinsky DA. Kidney stones. In: Williams Textbook of Endocrinology, edited by Kronenberg HM, Melmed S, Polonsky KS, Larsen PR. Philadelphia: W. B. Saunders, 2011, p. 1350-1367.
51. 2+ channel TRPV6 in the kidney. J Am Soc Nephrol 14: 2731-2740, 2003.
52. Perry GML, Nehrke KW, Bushinsky DA, Reid R, Lewandowski KL, Hueber P, Scheinman SJ. Sex modifies genetic effects on residual variance in urinary calcium excretion in rat (Rattus norvegicus). Genetics 191: 1003-1013, 2012.
53. Shen FH, Baylink DJ, Nielsen RL. Increased serum 1,25-dihydroxy cholecalciferol (1,25 diOHD3) in patients with idiopathic hypercalciuria (IH). Clin Res 23: 423A, 1975.
54. Shinki T, Shimada H, Wakino S, Anazawa H, Hayashi M, Saruta T, DeLuca HF, Suda T. Cloning and expression of rat 25-hydroxyvitamin D3-1-hydroxylase cDNA. Proc Natl Acad Sci USA 94: 12920-12925, 1997.
55. Stechman MJ, Loh NY, Thakker RV. Genetics of hypercalciuric nephrolithiasis: renal stone disease. Acad Sci 1116: 461-484, 2007.
56. Thorleifsson G, Holm H, Edvardsson V, Walters GB, Styrkarsdottir U, Gudbjartsson DF, Sulem P, Halldorsson BV, de VF, d'Ancona FC, den HM, Franzson L, Christiansen C, Alexandersen P, Rafnar T, Kristjansson K, Sigurdsson G, Kiemeney LA, Bodvarsson M, Indridason OS, Palsson R, Kong A, Thorsteinsdottir U, Stefansson K. Sequence variants in the CLDN14 gene associate with kidney stones and bone mineral density. Nat Genet 41: 926-930, 2009.
57. Tsuruoka S, Bushinsky DA, Schwartz GJ. Defective renal calcium reabsorption in genetic hypercalciuric rats. Kidney Int 51: 1540-1547, 1997.
58. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3: research0034.1-research0034.11, 2002.
59. Wang W, Kwon TH, Li C, Frøkiær J, Knepper MA, Nielsen S. Reduced expression of Na-K-2Cl cotransporter in medullary TAL in vitamin D-induced hypercalcemia in rats. Am J Physiol Renal Physiol 282: F34-F44, 2002.
60. Werness PG, Brown CM, Smith LH, Finlayson B. Equil2: a BASIC computer program for the calculation of urinary saturation. J Urol 134: 1242-1244, 1985.
61. Yao J, Karnauskas AJ, Bushinsky DA, Favus MJ. Regulation of renal calcium-sensing receptor gene expression in response to 1,25(OH)2D3 in genetic hypercalciuric stone forming rats. J Am Soc Nephrol 16: 1300-1308, 2005.
62. Yao J, Kathpalia P, Bushinsky DA, Favus MJ. Hyperresponsiveness of vitamin D receptor gene expression to 1,25-dihydroxyvitamin D3: a new characteristic of genetic hypercalciuric stone-forming rats. J Clin Invest 101: 2223-2232, 1998.
63. Zerwekh JE, Reed BY, Heller HJ, Gonzalez GB, Haussler MR, Pak CY. Normal vitamin D receptor concentration and responsiveness to 1,25-dihydroxyvitamin D3 in skin fibroblasts from patients with absorptive hypercalciuria. Miner Electrolyte Metab 24: 307-313, 1998.